Short-chain peptides · GHRP-2

• Identity: Hexapeptide D-Ala-D-2Nal-Ala-Trp-D-Phe-Lys-NH2 (pralmorelin)
• Format: lyophilised powder, 5 mg/vial
• Purity & identity: per batch COA, HPLC + ESI-MS (see COA vault)

Store lyophilised at −20 °C, protected from light and moisture. To be handled only by qualified, trained personnel in a suitably equipped laboratory, using appropriate personal protective equipment. Consult the safety data sheet before use (to be provided).

This product is intended exclusively for scientific research and development purposes (in vitro). It must not be used as a medicinal product, drug, active substance or starting material for one, as a medical device, for any diagnostic or therapeutic purpose, as a food or food supplement, as a cosmetic or cosmetic ingredient, in sport, or otherwise on humans or animals. Typical in-vitro applications include receptor–ligand binding studies, enzyme activity assays, cell-based assays and analytical method development.

This material may not be:

• used in clinical trials involving humans;
• administered to humans or animals as part of any experiment or investigation;
• supplied to another party for human or veterinary use.

Morelin provides no information on use in humans or animals and makes no claims about effects. Questions about dosing, effects or human use will not be answered.

Due to legal and regulatory requirements, this product may not be shipped to certain countries. The list per product will be confirmed by counsel before launch (placeholder). Buyers are responsible for checking that import is permitted in the country of delivery.